CALYM (French: Consortium pour l’Accélération de l’innovation et de son transfert dans le domaine du LYMphome, or Consortium to Accelerate Innovation and the Transfer in the Domain of Lymphoma) is a lymphoma research consortium that consists of two non-profit associations (LYSA and LYSARC) – 13 French research entities with preclinical and clinical research expertise in the field of lymphoma.